World's Best Scientists 2026 revealed!
Award Badge
Medicine
UK
2023

D-Index & Metrics

Medicine

D-Index
154
Citations
111906
World Ranking
991
National Ranking
103

Research.com Recognitions

  • 2023 - Research.com Medicine in United Kingdom Leader Award

Overview

Roger Williams was a researcher affiliated with the Foundation for Liver Research in the United Kingdom. Their scientific work covered multiple fields within medicine and biological sciences, with a focus on the study and treatment of liver disease, as well as research into cancer and bacterial infections.

The main fields of study in which Williams published included Medicine and Biochemistry, Genetics and Molecular Biology. Their subfields spanned Endocrinology, Epidemiology, Molecular Biology, Oncology, and Neurology.

The topics they frequently investigated encompassed:

  • Legionella and Acanthamoeba research
  • Bacterial biofilms and quorum sensing
  • Vibrio bacteria research studies
  • Neuroendocrine Tumor Research Advances
  • Lung Cancer Research Studies
  • Neuroblastoma Research and Treatments
  • Liver Disease Diagnosis and Treatment

Williams contributed to a number of scientific papers between 2020 and 2025 published in peer-reviewed journals. Some recent publications include:

  • "Acanthamoebae as a protective reservoir for Pseudomonas aeruginosa in a clinical environment," 2024, Journal of Hospital Infection
  • "Identification of soluble immune checkpoint receptor landscape in liver metastases of neuroendocrine neoplasms: A new perspective for immunotherapy," 2020, Endocrine Abstracts
  • "P2.04A.06 A Multilevel Approach to Address Disparities in Lung Cancer Screening: The PREP Trial," 2024, Journal of Thoracic Oncology
  • "P1.04.10 Lung Cancer Screening Completion Rates as Predicted by Social Deprivation," 2025, Journal of Thoracic Oncology

The journals where Williams most frequently published include the Journal of Thoracic Oncology, Journal of Hospital Infection, and Endocrine Abstracts.

Throughout their career, Williams collaborated often with coauthors such as K.L. Taylor, G. Luta, Anu Sangraula, Scott Melvin, and Robert A. Mooney.

Williams's research spanned clinical and molecular investigations related to infectious diseases, immune checkpoint mechanisms in liver metastases, and disparities in lung cancer screening. Their multidisciplinary approach bridged clinical medicine and molecular biology in studying complex disease pathways.

Best Publications

  • Transection of the oesophagus for bleeding oesophageal varices

    R. N. H. Pugh;I. M. Murray‐Lyon;J. L. Dawson;M. C. Pietroni

  • Early indicators of prognosis in fulminant hepatic failure

    John G. O'Grady;Graeme J.M. Alexander;Karen M. Hayllar;Roger Williams

  • Acute liver failure: redefining the syndromes

    J G O'Grady;S W Schalm;R Williams

  • Long-Term Outcome of Hepatitis C Infection after Liver Transplantation

    Edward J. Gane;Bernard C. Portmann;Nikolai V. Naoumov;Heather M. Smith

  • Global challenges in liver disease

    Roger Williams

  • Addressing liver disease in the UK: A blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis

    Roger Williams;Richard Aspinall;Mark Bellis;Ginette Camps-Walsh

  • Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure.

    John G. O'Grady;A.E.S. Gimson;C.J. O'Brien;A. Pucknell

  • Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis.

    S. E. Davies;B. C. Portmann;J. G. O'grady;P. M. Aldis

  • Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?

    I. G. McFarlane;H. M. Smith;P. J. Johnson;G. P. Bray

  • CONTROLLED TRIAL OF PREDNISONE AND AZATHIOPRINE IN ACTIVE CHRONIC HEPATITIS

    IainM Murray-Lyon;R.B Stern;Roger Williams

  • Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London.

    I T Gilmore;A Burroughs;I M Murray-Lyon;R Williams

  • Treatment of Hepatic Encephalopathy

    Stephen M. Riordan;Roger Williams

  • INFLUENCE OF DELTA INFECTION ON SEVERITY OF HEPATITIS B

    Antonina Smedile;Giorgio Verme;Antonietta Cargnel;Pietro Dentico

  • FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms

    Martin Siewert;Jennifer Dressman;Cynthia K. Brown;Vinod P. Shah

  • Natural history and prognostic variables in primary sclerosing cholangitis

    J.Mark Farrant;Karen M. Hayllar;Mark L. Wilkinson;John Karani

  • Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: Evidence that T cells are directed against HBV core antigen expressed on hepatocytes

    M Mondelli;G M Vergani;A Alberti;D Vergani

  • Liver transplantation for malignant disease. Results in 93 consecutive patients.

    J G O'Grady;R J Polson;K Rolles;R Y Calne

  • A longitudinal analysis of hepatitis C virus replication following liver transplantation

    E. J. Gane;N. V. Naoumov;K.-P. Qian;M. U. Mondelli

  • Direct ex vivo analysis of hepatitis B virus-specific CD8+ T cells associated with the control of infection

    Mala K. Maini;Carolina Boni;Graham S. Ogg;Abigail S. King

  • Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis: Final results of an international trial

    Erik Christensen;James Neuberger;John Crowe;Douglas G. Altman

Frequent Co-Authors

Bernard Portmann
Bernard Portmann King's College London
Nikolai V. Naoumov
Nikolai V. Naoumov Novartis (Switzerland)
A. L. W. F. Eddleston
A. L. W. F. Eddleston University of Cambridge
Graeme J. M. Alexander
Graeme J. M. Alexander University College London
Rajiv Jalan
Rajiv Jalan University College London
John O'Grady
John O'Grady King's College London
Julia Wendon
Julia Wendon King's College London
Diego Vergani
Diego Vergani King's College London
Nigel Heaton
Nigel Heaton King's College London
Peter T. Donaldson
Peter T. Donaldson University of Newcastle Australia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students considering studying Medicine in the USA, there are several online degrees and alternative career pathways in healthcare that offer both flexibility and affordability. These programs are ideal for those looking to advance their careers while balancing existing work or family commitments.

Pursuing one of the most affordable mha programs can prepare you for leadership roles in hospitals, clinics, and other healthcare organizations. If your interest lies in advanced clinical practice, exploring cheap online dnp programs may offer the flexibility and cost-effectiveness you need as you grow your expertise.

Pharmacy is another vital field, with online pharmd programs providing a pathway to becoming a licensed pharmacist. Additionally, informatics is a rapidly expanding area in healthcare; earning your degree from an online mhi program can open opportunities in data management, policy, and IT within medical settings.

These online programs offer diverse options for advancing your healthcare career—often at a lower cost and with greater flexibility than traditional, on-campus routes.

Best Scientists Citing Roger Williams